Oppenheimer & CO Inc Fulgent Genetics, Inc. Transaction History

Oppenheimer & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$47.98 - $62.75 $269,647 - $352,655	-5,620 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$49.85 - $96.11 $41,923 - $80,828	-841 Reduced 13.02%	5,620 $351,000
Q4 2021 Feb 02, 2022	SELL	$77.3 - $105.0 $16,928 - $22,995	-219 Reduced 3.28%	6,461 $650,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $542,882 - $803,918	-7,251 Reduced 52.05%	6,680 $601,000
Q2 2021 Aug 03, 2021	BUY	$66.8 - $100.45 $373,478 - $561,615	5,591 Added 67.04%	13,931 $1.29 Million
Q1 2021 May 10, 2021	SELL	$59.3 - $183.85 $85,569 - $265,295	-1,443 Reduced 14.75%	8,340 $806,000
Q4 2020 Feb 11, 2021	SELL	$31.01 - $52.1 $135,606 - $227,833	-4,373 Reduced 30.89%	9,783 $510,000
Q3 2020 Nov 13, 2020	BUY	$15.89 - $50.51 $224,938 - $715,019	14,156 New	14,156 $567,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $571M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.